NCT06907498View on ClinicalTrials.gov

Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults

NARecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Dientamoeba Fragilis Infection

Interventions

DRUG

Paromomycin

Paromomycin 500mg X3 / day

Trial Locations (1)

52621

RECRUITING

Sheba medical center, Ramat Gan

All Listed Sponsors

lead

Sheba Medical Center

OTHER_GOV